TABLE 1.
At Listing (n = 69,213) | At LT (n = 23,446) | |
---|---|---|
Age (years)* | 54.1 (9.6) | 53.0 (9.7) |
Males [n (%)] | 45,666 (66) | 15,687 (67) |
Hepatitis C [n (%)] | 25,927 (37) | 8568 (37) |
Cholestatic cirrhosis [n (%)] | 5038 (7) | 2126 (9) |
Noncholestatic cirrhosis [n (%)] | 25,270 (37) | 10,188 (43) |
Caucasian race [n (%)] | 49,167 (71) | 17,100 (73) |
MELD score* | 16.7 (8.1) | 25.3 (8.4) |
Serum sodium (mmol/L)* | 136 (4.8) | 135 (5.4) |
Serum creatinine (mg/dL)* | 1.3 (1.2) | 1.8 (1.5) |
Serum bilirubin (mg/dL)* | 4.9 (7.6) | 10.8 (11.9) |
International normalized ratio* | 1.6 (0.7) | 2.1 (1.2) |
Renal replacement therapy [n (%)] | 2658 (3.8) | 3593 (15) |
Albumin (g/dL)* | 3.1 (0.7) | 2.9 (0.7) |
The data are presented as means (with standard deviations in parentheses).